| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0922-4106(93)90009-X |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:092241069390009X?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:092241069390009X?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 7689059 |
| P2093 | author name string | B. Tümmler | |
| T. Hoof | |||
| U. Christians | |||
| A. Demmer | |||
| P2860 | cites work | Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase | Q28320515 |
| Cyclosporins as drug resistance modifiers | Q35250358 | ||
| Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives | Q36467823 | ||
| Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands | Q36617985 | ||
| Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro | Q40922557 | ||
| FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin | Q41618754 | ||
| Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies | Q42812351 | ||
| Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON | Q54265673 | ||
| Reversal of multidrug resistance by an immunosuppressive agent FK-506 | Q67531345 | ||
| Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein | Q69375792 | ||
| Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil | Q70721995 | ||
| CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered beta-tubulin | Q71235913 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 53-58 | |
| P577 | publication date | 1993-06-01 | |
| 1993-06-15 | |||
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Reversal of multidrug resistance in Chinese hamster ovary cells by the immunosuppressive agent rapamycin | |
| P478 | volume | 246 |
| Q41020870 | Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants. |
| Q44067347 | Colchicine myoneuropathy in a renal transplant patient |
| Q41187112 | Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P-glycoprotein |
| Q30491780 | Hypoxia as a target for drug combination therapy of liver cancer. |
| Q40991711 | In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin |
| Q43619915 | Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors |
| Q34791985 | Mechanisms of clinically relevant drug interactions associated with tacrolimus |
| Q34478635 | Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? |
| Q73429640 | Modulation of Multidrug Resistance in Cancer by Immunosuppresive Agents. Preclinical Studies |
| Q24815638 | Overcoming cisplatin resistance by mTOR inhibitor in lung cancer |
| Q34303346 | Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation |
| Q35187824 | Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein |
| Q38985758 | RAD001 can reverse drug resistance of SGC7901/DDP cells |
| Q54585965 | Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus. |
| Q34680333 | The medicinal chemistry of multidrug resistance (MDR) reversing drugs |
Search more.